Cargando…

Excitatory neurotransmitters in brain regions in interictal migraine patients

OBJECTIVE: To examine biochemical differences in the anterior cingulate cortex (ACC) and insula during the interictal phase of migraine patients. We hypothesized that there may be differences in levels of excitatory amino acid neurotransmitters and/or their derivatives in migraine group based on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Prescot, Andrew, Becerra, Lino, Pendse, Gautam, Tully, Shannon, Jensen, Eric, Hargreaves, Richard, Renshaw, Perry, Burstein, Rami, Borsook, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714306/
https://www.ncbi.nlm.nih.gov/pubmed/19566960
http://dx.doi.org/10.1186/1744-8069-5-34
_version_ 1782169662903025664
author Prescot, Andrew
Becerra, Lino
Pendse, Gautam
Tully, Shannon
Jensen, Eric
Hargreaves, Richard
Renshaw, Perry
Burstein, Rami
Borsook, David
author_facet Prescot, Andrew
Becerra, Lino
Pendse, Gautam
Tully, Shannon
Jensen, Eric
Hargreaves, Richard
Renshaw, Perry
Burstein, Rami
Borsook, David
author_sort Prescot, Andrew
collection PubMed
description OBJECTIVE: To examine biochemical differences in the anterior cingulate cortex (ACC) and insula during the interictal phase of migraine patients. We hypothesized that there may be differences in levels of excitatory amino acid neurotransmitters and/or their derivatives in migraine group based on their increased sensitivity to pain. METHODS: 2D J-resolved proton magnetic resonance spectroscopy ((1)H-MRS) data were acquired at 4.0 Tesla (T) from the ACC and insula in 10 migraine patients (7 women, 3 men, age 43 ± 11 years) and 8 age gender matched controls (7 women, 3 men, age 41 ± 9 years). RESULTS: Standard statistical analyses including analysis of variance (ANOVA) showed no significant metabolite differences between the two subject cohorts in the ACC nor the insula. However, linear discriminant analysis (LDA) introduced a clear separation between subject cohorts based on N-acetyl aspartylglutamate (NAAG) and glutamine (Gln) in the ACC and insula. CONCLUSION: These results are consistent with glutamatergic abnormalities in the ACC and insula in migraine patients during their interictal period compared to healthy controls. An alteration in excitatory amino acid neurotransmitters and their derivatives may be a contributing factor for migraineurs for a decrease in sensitivity for migraine or a consequence of the chronic migraine state. Such findings, if extrapolated to other regions of the brain would offer new opportunities to modulate central system as interictal or preemptive medications in these patients.
format Text
id pubmed-2714306
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27143062009-07-23 Excitatory neurotransmitters in brain regions in interictal migraine patients Prescot, Andrew Becerra, Lino Pendse, Gautam Tully, Shannon Jensen, Eric Hargreaves, Richard Renshaw, Perry Burstein, Rami Borsook, David Mol Pain Research OBJECTIVE: To examine biochemical differences in the anterior cingulate cortex (ACC) and insula during the interictal phase of migraine patients. We hypothesized that there may be differences in levels of excitatory amino acid neurotransmitters and/or their derivatives in migraine group based on their increased sensitivity to pain. METHODS: 2D J-resolved proton magnetic resonance spectroscopy ((1)H-MRS) data were acquired at 4.0 Tesla (T) from the ACC and insula in 10 migraine patients (7 women, 3 men, age 43 ± 11 years) and 8 age gender matched controls (7 women, 3 men, age 41 ± 9 years). RESULTS: Standard statistical analyses including analysis of variance (ANOVA) showed no significant metabolite differences between the two subject cohorts in the ACC nor the insula. However, linear discriminant analysis (LDA) introduced a clear separation between subject cohorts based on N-acetyl aspartylglutamate (NAAG) and glutamine (Gln) in the ACC and insula. CONCLUSION: These results are consistent with glutamatergic abnormalities in the ACC and insula in migraine patients during their interictal period compared to healthy controls. An alteration in excitatory amino acid neurotransmitters and their derivatives may be a contributing factor for migraineurs for a decrease in sensitivity for migraine or a consequence of the chronic migraine state. Such findings, if extrapolated to other regions of the brain would offer new opportunities to modulate central system as interictal or preemptive medications in these patients. BioMed Central 2009-06-30 /pmc/articles/PMC2714306/ /pubmed/19566960 http://dx.doi.org/10.1186/1744-8069-5-34 Text en Copyright © 2009 Prescot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Prescot, Andrew
Becerra, Lino
Pendse, Gautam
Tully, Shannon
Jensen, Eric
Hargreaves, Richard
Renshaw, Perry
Burstein, Rami
Borsook, David
Excitatory neurotransmitters in brain regions in interictal migraine patients
title Excitatory neurotransmitters in brain regions in interictal migraine patients
title_full Excitatory neurotransmitters in brain regions in interictal migraine patients
title_fullStr Excitatory neurotransmitters in brain regions in interictal migraine patients
title_full_unstemmed Excitatory neurotransmitters in brain regions in interictal migraine patients
title_short Excitatory neurotransmitters in brain regions in interictal migraine patients
title_sort excitatory neurotransmitters in brain regions in interictal migraine patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714306/
https://www.ncbi.nlm.nih.gov/pubmed/19566960
http://dx.doi.org/10.1186/1744-8069-5-34
work_keys_str_mv AT prescotandrew excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT becerralino excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT pendsegautam excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT tullyshannon excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT jenseneric excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT hargreavesrichard excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT renshawperry excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT bursteinrami excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients
AT borsookdavid excitatoryneurotransmittersinbrainregionsininterictalmigrainepatients